Atlas Trials

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

Clinical trial NCT03101514 · COMPLETED

Trial details

NCT number
NCT03101514
Sponsor
First Affiliated Hospital of Harbin Medical University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck CancerRadiotherapy
Start date
2017-01-01
Primary completion
2021-02-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.